NCT06857370View on ClinicalTrials.gov

Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

780

Participants

Timeline

Start Date

March 23, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Diphtheria, Tetanus and Acellular Pertussis
Interventions
BIOLOGICAL

Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP Lot 1)

Three doses of basic immunization were completed at 2, 4 and 6 months of age

BIOLOGICAL

Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP Lot 2)

Three doses of basic immunization were completed at 2, 4 and 6 months of age

BIOLOGICAL

Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP Lot 3)

Three doses of basic immunization were completed at 2, 4 and 6 months of age

Trial Locations (1)

461500

Changge Center for Disease Control and Prevention, Xuchang

Sponsors
All Listed Sponsors
lead

CanSino Biologics Inc.

INDUSTRY

NCT06857370 - Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine | Biotech Hunter | Biotech Hunter